A kind of recombinant virus expressing classical swine fever virus e2 gene and its preparation method and application
A recombinant virus, swine fever virus technology, applied in the directions of botanical equipment and methods, biochemical equipment and methods, applications, etc., can solve the problems of drug substitution and immune clinical disease, and achieve the effect of increasing the expression amount
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0041] Construction of a recombinant baculovirus Ac-CSE12 expressing the immunogenic gene E2 gene of CSFV
[0042] (1), construction of recombinant baculovirus Ac-CSE12
[0043] 1. Acquisition of the main immunogenic gene E2 of CSFV
[0044] With reference to the E2 gene sequence (GenBank No.FJ456876) of the CSFV QZ-07 isolate (2.1 type swine fever virus), the E2 gene sequence of 1222bp was artificially synthesized according to the preference of baculovirus codons, and the sequence was cloned into the vector pUC-18( Invitrogen Company) obtained the recombinant plasmid pUC-57-2.1-E2.
[0045] Using the plasmid pMD-18T-CSFV-E2 (containing the E2 gene of the rabbitized attenuated vaccine strain of classical swine fever virus HCLV, master student: Tan Huaju; supervisor: Qian Ping; Huazhong Agricultural University 2009 master's thesis: BVDV E2 gene recombinant classical swine fever virus Construction and expression of porcine IRF3 / 7 clones) as templates, using primers 1.1E2-GZF a...
Embodiment 2
[0071] Subunit vaccine prepared by recombinant baculovirus Ac-CSE12 of the present invention and immune efficacy experiment
[0072] 1. The subunit vaccine prepared by the recombinant baculovirus Ac-CSE12 of the present invention
[0073] The recombinant baculovirus Ac-CSE12 obtained in Example 1 was used to inoculate the suspension-cultured insect cells High Five at a MOI dose of 1.0 TM (purchased from Invitrogen Company), after 72 hours, the cells and supernatant were collected, processed by a cell disruptor, centrifuged to remove cell debris, and after measuring the protein concentration, it was emulsified with 206 adjuvant (purchased from SEPPIC Company) to prepare a sub-vaccine. The protein content of CSFV E2 in the medium is 40 micrograms, used in the following examples, and stored at 4°C.
[0074] 2. Inspection of subunit vaccine technical indicators prepared by recombinant baculovirus Ac-CSE12 of the present invention
[0075] (1) Physical shape
[0076] Appearance ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com